Zhi Qin

Dr. Zhi Qin


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2023 in Trials
Verified
Journal Article
Open access
PDF file
NHNingqing Huang
Ningqing Huang
ZQZhi Qin
Zhi Qin
WSWudong Sun
Wudong Sun
KBKaiming Bao
Kaiming Bao
JZJingxian Zha
Jingxian Zha
MMMing Ma
Ming Ma
Background: Chronic prostatitis/chronic pelvic pain syndrome is a highly prevalent syndrome. Previous studies showed that extracorporeal shockwave therapy and myofascial release therapy could improve the quality of life in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Theoretically, combined therapy with extracorporeal shockwave therapy and myofascial release therapy will likely have significant advantages in treating CP/CPPS. We, therefore, present a protocol for conducting a well-designed randomized controlled trial to compare the efficacy and safety of each therapy. Methods: The proposed study will be a three-group randomized control trial (RCT) design that includes 150 participants from Zhongda Hospital Affiliated to Southeast University, with equal allocation of participants to the three intervention groups. The study duration will be 8 weeks, which includes a 4-week treatment period and a 4-week follow-up period. The primary outcome will be the changes in surface electromyography (sEMG) assessment and National Institutes of Health-Chronic Prostatitis Symptom Index (NIH-CPSI). The secondary outcomes will include the changes in three-dimensional quantification, shear wave elastography (SWE), and sympathetic skin response (SSR) testing. Assessments will be conducted before the intervention (T0), before the 5th intervention (T1), immediately after the 8th intervention (T2), and the 4th week after the end of the 8th intervention (T3). Discussion: This trial will compare the differences in efficacy between single extracorporeal shockwave therapy, single myofascial release therapy, and combined therapy to select the most appropriate treatment option for patients with CP/CPPS. The possible pathogenesis of CP/CPPS would also be analyzed by comparing the intercorrelation between each objective and subjective measurement (NIH-CPSI score, sEMG, SWE, SSR). Trial registration: The name of the registry: Extracorporeal Shockwave and Myofascial Release Therapy in Chronic Pelvic Pain Syndrome. Registration number: NCT05659199. Date of registration: December 2022.

31 March 2026 in European Journal of Radiology
Verified
Journal Article
Closed access
ZQZhi Qin
Zhi Qin
QGQianhui Gui
Qianhui Gui
MBMouxiao Bian
Mouxiao Bian
RWRui Wang
Rui Wang
HGHong Ge
Hong Ge
YWYuan‑Cheng Wang
Yuan‑Cheng Wang